- Home
- CLPT vs RNAC Comparison
CLPT vs RNAC Comparison
Compare CLPT & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- RNAC
- Stock Information
- Founded
- CLPT 1998
- RNAC 2007
- Country
- CLPT United States
- RNAC United States
- Employees
- CLPT N/A
- RNAC N/A
- Industry
- CLPT Medical/Dental Instruments
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- RNAC Health Care
- Exchange
- CLPT Nasdaq
- RNAC Nasdaq
- Market Cap
- CLPT 317.4M
- RNAC 276.3M
- IPO Year
- CLPT N/A
- RNAC 2016
- Fundamental
- Price
- CLPT $10.49
- RNAC $10.05
- Analyst Decision
- CLPT Strong Buy
- RNAC Strong Buy
- Analyst Count
- CLPT 3
- RNAC 4
- Target Price
- CLPT $27.67
- RNAC $40.00
- AVG Volume (30 Days)
- CLPT 375.5K
- RNAC 48.4K
- Earning Date
- CLPT 08-12-2025
- RNAC 08-07-2025
- Dividend Yield
- CLPT N/A
- RNAC N/A
- EPS Growth
- CLPT N/A
- RNAC N/A
- EPS
- CLPT N/A
- RNAC N/A
- Revenue
- CLPT $33,593,000.00
- RNAC $1,026,000.00
- Revenue This Year
- CLPT $22.34
- RNAC N/A
- Revenue Next Year
- CLPT $25.50
- RNAC N/A
- P/E Ratio
- CLPT N/A
- RNAC N/A
- Revenue Growth
- CLPT 19.68
- RNAC N/A
- 52 Week Low
- CLPT $9.76
- RNAC $8.46
- 52 Week High
- CLPT $19.22
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- CLPT 44.46
- RNAC 34.71
- Support Level
- CLPT $10.42
- RNAC $10.50
- Resistance Level
- CLPT $10.88
- RNAC $11.80
- Average True Range (ATR)
- CLPT 0.52
- RNAC 0.56
- MACD
- CLPT -0.01
- RNAC -0.11
- Stochastic Oscillator
- CLPT 22.75
- RNAC 0.45
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.